Dialogue Health Technologies Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Dialogue Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Dialogue Health Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Dialogue Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 42.1 M | |
| Total Cashflows From Investing Activities | -5 M |
Dialogue |
Dialogue Health Relative Risk vs. Return Landscape
If you would invest (100.00) in Dialogue Health Technologies on October 29, 2025 and sell it today you would earn a total of 100.00 from holding Dialogue Health Technologies or generate -100.0% return on investment over 90 days. Dialogue Health Technologies is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Dialogue, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Dialogue Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dialogue Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dialogue Health Tech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Dialogue Health Tech is not yet fully synchronised with the market data | |
| Dialogue Health Tech has some characteristics of a very speculative penny stock | |
| Dialogue Health Tech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 68.05 M. Net Loss for the year was (251.35 M) with profit before overhead, payroll, taxes, and interest of 28.81 M. | |
| Dialogue Health Technologies has accumulated about 61.06 M in cash with (23.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Roughly 15.0% of the company shares are held by company insiders |
Dialogue Health Fundamentals Growth
Dialogue Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Dialogue Health, and Dialogue Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dialogue Pink Sheet performance.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.33) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 78.04 M | |||
| Shares Outstanding | 66.34 M | |||
| Price To Earning | 6.90 X | |||
| Price To Book | 1.84 X | |||
| Price To Sales | 1.58 X | |||
| Revenue | 68.05 M | |||
| EBITDA | (248.85 M) | |||
| Cash And Equivalents | 61.06 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 1.07 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (23.28 M) | |||
| Earnings Per Share | 0.31 X | |||
| Total Asset | 135.25 M | |||
Things to note about Dialogue Health Tech performance evaluation
Checking the ongoing alerts about Dialogue Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Dialogue Health Tech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dialogue Health Tech is not yet fully synchronised with the market data | |
| Dialogue Health Tech has some characteristics of a very speculative penny stock | |
| Dialogue Health Tech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 68.05 M. Net Loss for the year was (251.35 M) with profit before overhead, payroll, taxes, and interest of 28.81 M. | |
| Dialogue Health Technologies has accumulated about 61.06 M in cash with (23.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93. | |
| Roughly 15.0% of the company shares are held by company insiders |
- Analyzing Dialogue Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dialogue Health's stock is overvalued or undervalued compared to its peers.
- Examining Dialogue Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dialogue Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dialogue Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dialogue Health's pink sheet. These opinions can provide insight into Dialogue Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Dialogue Pink Sheet
If you are still planning to invest in Dialogue Health Tech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dialogue Health's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |